-
-
Call more information
660-596-2224 -
Author: Muhammad A. Farooq Anwar, MD, MBA et al ASA Monitor June 2024, Vol. 88, 1–6. The IOM report “Relieving Pain in America” indicates that racial and socioeconomic disparities in pain treatment are common. There is a paucity of data regarding disparities in innovative pain procedures. Two existing studies discuss profound racial differences in patients receiving […]
Read MoreNovel gene therapy reduces risk of motor impairment in MLD The FDA has approved Lenmeldy (atidarsagene autotemcel) as the first gene therapy for children with presymptomatic late infantile, pre-symptomatic early juvenile, or early symptomatic early juvenile metachromatic leukodystrophy (MLD). MLD is a rare genetic disease affecting the brain and nervous system due to a deficiency […]
Read MoreASA Monitor June 2024, Vol. 88, 8. A 49-year-old female was scheduled for an urgent transesophageal echo (TEE) to rule out intracardiac thrombosis before cardioversion due to new onset atrial fibrillation with rapid ventricular rate. At this institution, the TEEs are done in a procedure room without an anesthesia machine under TIVA sedation, with necessary back […]
Read MoreASA Monitor June 2024, Vol. 88, 7 Recently, researchers compared ejection fraction values derived from conventional two-dimensional (2D) transthoracic echocardiography to those generated by a wearable device that uses acoustic sensors, electrocardiographic signals, and machine learning to generate a value. How did the measurements from the wearable device MOST likely compare to those derived from 2D […]
Read MoreAuthor: Pamela Schumacher ASA Monitor June 2024, Vol. 88, The FIVA Flow attaches to any standard gravity-fed I.V. set to monitor fluid flow. It has been used since January 2023. The scene is typical – a dim OR filled with distracting noises, beeps, alarms, conversations, and the whine of surgical instruments. The anesthesiologist is busy […]
Read MoreWHO announces new AI resource The World Health Organization (WHO) has unveiled the Smart AI Resource Assistant for Health, or S.A.R.A.H., a digital health promoter prototype that uses generative artificial intelligence (AI) with enhanced empathetic response capabilities. S.A.R.A.H. operates 24/7 in eight languages across various devices, offering guidance on diverse health topics like healthy habits […]
Read MoreNonopioid postsurgical pain treatment option approved Cumberland Pharmaceuticals Inc. has announced U.S. Food and Drug Administration (FDA) approval of Caldolor® (intravenous ibuprofen, or IVIB) as a standard treatment for pain and fever across various patient demographics. Caldolor offers multimodal pain management, with clinical studies demonstrating IVIB’s significant efficacy in reducing temperature compared to placebo or acetaminophen, […]
Read MoreASA Monitor June 2024, Vol. 88, 6. Which of the following is MOST likely to be associated with an increased risk for postoperative urinary retention (POUR)? (A) Decreased intraoperative fluids (B) Male sex (C) Gynecologic surgery POUR is a common postsurgical complication. Depending on multiple interacting factors, the incidence ranges from 5%-70% (Table). Interdependence between risk […]
Read MoreInjectable approved to reduce liver fat content A National Institutes of Health (NIH)-funded study revealed that a weekly injection of semaglutide is safe and reduces liver fat by 31% in individuals with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD). MASLD, previously known as nonalcoholic fatty liver disease, is a common chronic liver disease associated […]
Read MoreOver-the-counter glucose monitor expands access to diabetes care In March, the FDA approved the Dexcom Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor (CGM). This integrated CGM is for adults 18 and older who don’t use insulin, including those managing diabetes with oral medications or nondiabetics seeking to understand the effects of diet […]
Read More